# Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia

> **NCT02153788** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 44 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Temazepam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02153788
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** —
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2015-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153788, "Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02153788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*